Cmg Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 31-08-2024
- Paid Up Capital ₹ 2.04 Cr
as on 31-08-2024
- Company Age 19 Year, 22 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.05 Cr
as on 31-08-2024
- Satisfied Charges ₹ 0.70 M
as on 31-08-2024
- Revenue 1.78%
(FY 2023)
- Profit -8.75%
(FY 2023)
- Ebitda 37.27%
(FY 2023)
- Net Worth 17.48%
(FY 2023)
- Total Assets 58.08%
(FY 2023)
About Cmg Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.04 Cr.
The company currently has active open charges totaling ₹12.05 Cr. The company has closed loans amounting to ₹0.70 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Gupta and Amit Singh serve as directors at the Company.
- CIN/LLPIN
U74899DL2005PTC143161
- Company No.
143161
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Cmg Biotech Private Limited offer?
Cmg Biotech Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, Anti Infective Drugs & Medicines, Antibacterial Drugs, Kidney Drugs, Anti Allergic Drug.
Who are the key members and board of directors at Cmg Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Gupta  | Director | 01-Dec-2005 | Current |
| Amit Singh | Director | 01-Feb-2019 | Current |
Financial Performance of Cmg Biotech.
Cmg Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.78% increase. The company also saw a slight decrease in profitability, with a 8.75% decrease in profit. The company's net worth Soared by an impressive increase of 17.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cmg Biotech?
In 2023, Cmg Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Jan 2023 | ₹2.20 Cr | Open |
Others Creation Date: 07 Jun 2021 | ₹9.65 Cr | Open |
Others Creation Date: 10 Apr 2019 | ₹2.00 M | Open |
How Many Employees Work at Cmg Biotech?
Cmg Biotech has a workforce of 75 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cmg Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cmg Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
